ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Pharmacological Enhancement of Bile Duct Preservation and Function during Ex-Situ Normothermic Machine Perfusion

Y. L. Boteon, J. Attard, A. P. Boteon, L. Wallace, G. Reynolds, D. Mirza, H. Mergental, R. Bhogal, S. Afford

Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom

Meeting: 2019 American Transplant Congress

Abstract number: B61

Keywords: Bile duct, Donors, marginal, Liver preservation, Machine preservation

Session Information

Session Name: Poster Session B: Biomarkers, Immune Monitoring and Outcomes

Session Type: Poster Session

Date: Sunday, June 2, 2019

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Hall C & D

*Purpose: Whilst ex-situ normothermic machine perfusion (NMP) of the liver limits the ischaemic injury to the organ, benefits for biliary complications post-transplantation are not yet clear. Pharmacological enhancement of the hepatic lipid metabolism during NMP was shown to mitigate oxidative mediated inflammatory tissue damage. This study aims to assess whether this treatment improves biliary cell function and enhances its preservation during NMP.

*Methods: Eight discarded human donor livers were randomly allocated to two experimental groups: the control group and the treatment group (n=4), wherein the perfusate was supplemented with the drugs. Liver tissue, perfusate and bile were sampled systematically. Common hepatic duct biopsies (beginning and end of perfusion) were assessed for injury markers (damage to the lining epithelium, epithelial superficial/deep peribiliary glands, stromal necrosis, mural bleeding and thrombosis). Immunohistochemistry was performed for cytokeratin (CK)19, for integrity of the epithelial cells, and for cluster of differentiation (CD)31, for the endothelial cells.

*Results: The experimental groups are comparable in terms of donor type, warm and cold ischaemia time. Treated livers exhibit increased bile production (1.7[1.6-2.6]vs. 0.6[0.7-1.7]ml/h,p=0.021) and improved bile quality- bile pH (7.8[7.7-8.0]vs. 7.3[7.1-7.6],p=0.030). Histologically, at the end of the perfusion, bile ducts from the treated livers demonstrated less injury to the biliary epithelial cells (CK19+;p=0.024) and endothelial cells (CD31+;p=0.005) when compared to the controls. There is a strong correlation between the decreased activation of inflammatory cells (CD11b+) and the reduction in injuries to the biliary epithelial ([Spearman]r=0.813,p=0.042) and endothelial cells (r=0.703, p=0.05). Organs exhibiting better preserved biliary epithelial cells tend to produce higher volumes of bile (r=0.624,p=0.099), as well as better quality bile (r=0.620,p=0.100).

*Conclusions: This study suggests the possibility of pharmacological enhancement of bile duct preservation during NMP, potentially via mitigation of the inflammatory mediated injury. This finding might guide studies aiming to further improve biliary complication rates following NMP.

 border=

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Boteon YL, Attard J, Boteon AP, Wallace L, Reynolds G, Mirza D, Mergental H, Bhogal R, Afford S. Pharmacological Enhancement of Bile Duct Preservation and Function during Ex-Situ Normothermic Machine Perfusion [abstract]. Am J Transplant. 2019; 19 (suppl 3). https://atcmeetingabstracts.com/abstract/pharmacological-enhancement-of-bile-duct-preservation-and-function-during-ex-situ-normothermic-machine-perfusion/. Accessed May 11, 2025.

« Back to 2019 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences